India’s pharma industry warns that the Iran war’s ripple effects on input costs may push prices of essential drugs up by 3 to 5 percent in the near term. The increase is expected to last about 3 to 4 months, but companies are keeping the door open for a rollback if costs stabilise, bringing prices back closer to recent levels.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
